Daniel Dorgan

Randomized Trial of Liposomal Amikacin for Inhalation in Nontuberculous Mycobacterial Lung Disease

Kenneth N. Olivier, David E. Griffith, Gina Eagle et al. · American Journal of Respiratory and Critical Care Medicine · 2016 · 242 citations

Inhaled mRNA therapy for treatment of cystic fibrosis: Interim results of a randomized, double‐blind, placebo‐controlled phase 1/2 clinical study

Steven M. Rowe, Jonathan B. Zuckerman, Daniel Dorgan et al. · Journal of Cystic Fibrosis · 2023 · 119 citations · Full text

Pulmonary Care, Allergy, Pulmonary Pharmacology +4

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel, multicentre, open-label, randomised, controlled, non-inferiority trials

Nicole Mayer-Hamblett, Félix Ratjen, Renee Russell et al. · The Lancet Respiratory Medicine · 2022 · 116 citations · Full text

Medicine, Hypertonic Saline, Dornase Alfa +1

T2R38 genotype is correlated with sinonasal quality of life in homozygous ΔF508 cystic fibrosis patients

Nithin D. Adappa, Alan D. Workman, Denis Hadjiliadis et al. · International Forum of Allergy & Rhinology · 2015 · 53 citations · Full text

The presence of Aspergillus fumigatus is associated with worse respiratory quality of life in cystic fibrosis

Gina Hong, Kevin Alby, Sharon C.W. Ng et al. · Journal of Cystic Fibrosis · 2019 · 36 citations · Full text

Worse Respiratory Quality, Aspergillus Fumigatus, Respiratory Infection +6